Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Cardiotoxicity 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 7Cetuximab 6Radiotherapy 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3pembrolizumab 2Radiation 2Psychiatric Rehabilitation 2Nicotine 2Hydroxyurea 2Drug Therapy 2Counseling 2Celecoxib 2Bupropion 2sodium thiosulfate 1sargramostim 1motexafin gadolinium 1eniluracil 1durvalumab 1Zinc Oxide 1Varenicline 1Tobacco Use Cessation Devices 1Surgical Procedures, Operative 1Semaxinib 1Referral and Consultation 1Protons 1Proton Therapy 1Polymerase Chain Reaction 1Pilocarpine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypopharyngeal Neoplasms × Fluorophotometry × Clear all
NCT00002964 2013-02-05

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Roswell Park Cancer Institute

Phase 2 Completed
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡